Moyom Biotechnology Partners with WPP Group to Advance Aphranel's Global Brand Strategy in Regenerative Aesthetics
核心洞察
Moyom Biotechnology (搜索) has formed a strategic partnership with WPP Group (搜索) to enhance global brand communications for Aphranel (搜索), the first CaHA (搜索)-based regenerative injectable approved in China.
The collaboration centers on the "Poetics of Time" brand framework, which emphasizes respecting anatomy and long-term clinical value over traditional anti-aging approaches.
WPP will leverage its global resources across more than 100 countries to establish consistent international brand messaging for Aphranel (搜索)'s regenerative science platform.
Moyom Biotechnology (搜索) recently announced a strategic partnership with WPP Group (搜索), one of the world's leading global communications and creative networks, to advance the international brand positioning of Aphranel (搜索), its flagship regenerative injectable product. The collaboration focuses on the "Poetics of Time" brand framework and aims to strengthen Aphranel's global brand communications strategy.
Strategic Partnership Framework
WPP Group (搜索), headquartered in London and operating in more than 100 countries worldwide, will integrate its capabilities across creative, media, public relations, digital, consulting, and artificial intelligence to support Aphranel (搜索)'s brand development. The partnership is designed to help Aphranel establish a clear, consistent, and internationally relevant brand narrative while communicating the scientific and clinical approach behind the "Poetics of Time" philosophy to a broader professional audience.
Aphranel's Regulatory Position and Clinical Approach
Aphranel (搜索) represents a significant milestone as the first CaHA (搜索)-based regenerative injectable to receive regulatory approval in China. The brand is positioned around a return to core medical principles, emphasizing structural support and long-term biological processes that align with natural temporal rhythms.
The "Poetics of Time" framework reflects Aphranel (搜索)'s distinctive approach to aesthetic medicine, moving beyond traditional anti-aging concepts to focus on respecting anatomy, material science, and long-term clinical value. This philosophy represents a shift toward regenerative science integrated with clinically grounded, time-based medical principles.
Global Market Expansion Strategy
Through this partnership, Moyom Biotechnology (搜索) aims to expand Aphranel (搜索)'s international reach and build long-term brand trust across global markets. WPP's global resources and integrated expertise will be instrumental in establishing market-ready brand narratives that resonate with professional medical audiences worldwide.
The collaboration represents a key step in strengthening Aphranel (搜索)'s brand expression at the intersection of regenerative science and clinical medicine, positioning the company to compete in the evolving medical aesthetics landscape.
Company Background and Focus
Moyom Biotechnology (搜索) operates as a medical technology company dedicated to regenerative materials and professional medical aesthetics, with a focus on science-based solutions and sustainable innovation in healthcare delivery. Aphranel (搜索), as the company's core brand, specializes in facial injectables and regenerative materials, driven by science-based development and a sustained commitment to long-term clinical value for professional medical aesthetics applications.